Video head impulse gain is impaired in myotonic dystrophy types 1 and 2.

myotonic dystrophies refixation saccades vestibulopathy vestibulo‐ocular reflex video head impulse test

Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
15 Oct 2024
Historique:
revised: 16 09 2024
received: 28 04 2024
accepted: 24 09 2024
medline: 15 10 2024
pubmed: 15 10 2024
entrez: 15 10 2024
Statut: aheadofprint

Résumé

This study was undertaken to examine vestibulo-ocular reflex (VOR) characteristics in myotonic dystrophy type 1 (DM1) and type 2 (DM2) using video head impulse testing (vHIT). VOR gain, refixation saccade prevalence, first saccade amplitude, onset latency, peak velocity, and duration were compared in DM1, DM2, age-matched normal controls, and patients with peripheral and central vestibulopathies. Fifty percent of DM1 and 37.5% of DM2 patients demonstrated reduced VOR gain. Refixation saccade prevalence for horizontal canal (HC) and posterior canal (PC) was significantly higher in DM1 (101 ± 42%, 82 ± 47%) and DM2 (70 ± 45%, 61 ± 38%) compared to controls (40 ± 28% and 43 ± 33%, p < 0.05). The first saccade amplitudes and peak velocities were higher in HC and PC planes in DM1 and DM2 compared to controls (p < 0.05). HC slow phase eye velocity profiles in DM1 showed delayed peaks. The asymmetry ratio, which represents the percentage difference between the first and second halves of the slow phase eye velocity response, was therefore negative (-22.5 ± 17%, -2.3 ± 16%, and - 4.7 ± 8% in DM1, DM2, and controls). HC VOR gains were lower and gain asymmetry ratio was larger and negative in patients with DM1 with moderate to severe ptosis and a history of imbalance and falls compared to the remaining DM1 patients (p < 0.05). In peripheral vestibulopathies, saccade amplitude was larger, peak velocity was higher, and onset latency was shorter (p < 0.05) than in DM1. In central vestibulopathy (posterior circulation strokes), saccade peak velocity was higher, but amplitude and onset latency were not significantly different from DM1. VOR impairment is common in DM1 and DM2. In DM1, refixation saccade characteristics are closer to central than peripheral vestibulopathies. Delayed peaks in the vHIT eye velocity profile observed in patients with DM1 may reflect extraocular muscle weakness. VOR impairment and VOR asymmetry in DM1 are associated with imbalance and falls.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
This study was undertaken to examine vestibulo-ocular reflex (VOR) characteristics in myotonic dystrophy type 1 (DM1) and type 2 (DM2) using video head impulse testing (vHIT).
METHODS METHODS
VOR gain, refixation saccade prevalence, first saccade amplitude, onset latency, peak velocity, and duration were compared in DM1, DM2, age-matched normal controls, and patients with peripheral and central vestibulopathies.
RESULTS RESULTS
Fifty percent of DM1 and 37.5% of DM2 patients demonstrated reduced VOR gain. Refixation saccade prevalence for horizontal canal (HC) and posterior canal (PC) was significantly higher in DM1 (101 ± 42%, 82 ± 47%) and DM2 (70 ± 45%, 61 ± 38%) compared to controls (40 ± 28% and 43 ± 33%, p < 0.05). The first saccade amplitudes and peak velocities were higher in HC and PC planes in DM1 and DM2 compared to controls (p < 0.05). HC slow phase eye velocity profiles in DM1 showed delayed peaks. The asymmetry ratio, which represents the percentage difference between the first and second halves of the slow phase eye velocity response, was therefore negative (-22.5 ± 17%, -2.3 ± 16%, and - 4.7 ± 8% in DM1, DM2, and controls). HC VOR gains were lower and gain asymmetry ratio was larger and negative in patients with DM1 with moderate to severe ptosis and a history of imbalance and falls compared to the remaining DM1 patients (p < 0.05). In peripheral vestibulopathies, saccade amplitude was larger, peak velocity was higher, and onset latency was shorter (p < 0.05) than in DM1. In central vestibulopathy (posterior circulation strokes), saccade peak velocity was higher, but amplitude and onset latency were not significantly different from DM1.
CONCLUSIONS CONCLUSIONS
VOR impairment is common in DM1 and DM2. In DM1, refixation saccade characteristics are closer to central than peripheral vestibulopathies. Delayed peaks in the vHIT eye velocity profile observed in patients with DM1 may reflect extraocular muscle weakness. VOR impairment and VOR asymmetry in DM1 are associated with imbalance and falls.

Identifiants

pubmed: 39403824
doi: 10.1111/ene.16513
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e16513

Informations de copyright

© 2024 The Author(s). European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.

Références

Udd B, Krahe R. The myotonic dystrophies: molecular, clinical, and therapeutic challenges. Lancet Neurol. 2012;11(10):891‐905. doi:10.1016/S1474-4422(12)70204-1
Verhagen WIM, Ter Bruggen JP, Huygen PLM. Oculomotor, auditory, and vestibular responses in myotonic dystrophy. Arch Neurol. 1992;49(9):954‐960. doi:10.1001/archneur.1992.00530330078020
Versino M. Ocular motor myotonic phenomenon in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 2002;72(2):236‐240. doi:10.1136/jnnp.72.2.236
Balatsouras DG, Felekis D, Panas M, et al. Inner ear dysfunction in myotonic dystrophy type 1. Acta Neurol Scand. 2013;127(5):337‐343. doi:10.1111/ane.12020
Pisani V, Tirabasso A, Mazzone S, et al. Early subclinical cochlear dysfunction in myotonic dystrophy type 1: early cochlear dysfunction in DM1. Eur J Neurol. 2011;18(12):1412‐1416. doi:10.1111/j.1468-1331.2011.03470.x
Van Vliet J, Tieleman AA, van Engelen BGM, et al. Hearing impairment in patients with myotonic dystrophy type 2. Neurology. 2018;90(7):e615‐e622. doi:10.1212/WNL.0000000000004963
Kamsteeg E‐J, Kress W, Catalli C, et al. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2. Eur J Hum Genet. 2012;20(12):1203‐1208. doi:10.1038/ejhg.2012.108
Savić Pavićević D, Miladinović J, Brkušanin M, et al. Molecular genetics and genetic testing in myotonic dystrophy type 1. Biomed Res Int. 2013;2013:1‐13. doi:10.1155/2013/391821
Compston A. Aids to the investigation of peripheral nerve injuries. Medical Research Council: nerve injuries research committee. His Majesty's stationery office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By Michael O'Brien for the Guarantors of Brain. Saunders Elsevier: 2010; pp. [8] 64 and 94 figures. Brain. 2010;133(10):2838‐2844. doi:10.1093/brain/awq270
Peric S, Maksimovic R, Banko B, et al. Magnetic resonance imaging of leg muscles in patients with myotonic dystrophies. J Neurol. 2017;264(9):1899‐1908. doi:10.1007/s00415-017-8574-0
Mathieu J, Boivin H, Meunier D, Gaudreault M, Bégin P. Assessment of a disease‐specific muscular impairment rating scale in myotonic dystrophy. Neurology. 2001;56(3):336‐340. doi:10.1212/WNL.56.3.336
Finsterer J. Ptosis: causes, presentation, and management. Aesth Plast Surg. 2003;27(3):193‐204. doi:10.1007/s00266-003-0127-5
Halmagyi GM, Chen L, MacDougall HG, Weber KP, McGarvie LA, Curthoys IS. The video head impulse test. Front Neurol. 2017;8:258. doi:10.3389/fneur.2017.00258
Pogson JM, Taylor RL, Bradshaw AP, et al. The human vestibulo‐ocular reflex and saccades: normal subjects and the effect of age. J Neurophysiol. 2019;122(1):336‐349. doi:10.1152/jn.00847.2018
Jongkees LB, Maas JP, Philipszoon AJ. Clinical nystagmography. A detailed study of electro‐nystagmography in 341 patients with vertigo. Pract Otorhinolaryngol (Basel). 1962;24:65‐93.
Tarnutzer AA, Berkowitz AL, Robinson KA, Hsieh Y‐H, Newman‐Toker DE. Does my dizzy patient have a stroke? A systematic review of bedside diagnosis in acute vestibular syndrome. Can Med Assoc J. 2011;183(9):E571‐E592. doi:10.1503/cmaj.100174
Thornton CA, Johnson K, Moxley RT. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol. 1994;35(1):104‐107. doi:10.1002/ana.410350116
Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device‐based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and Antiarrhythmia devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117(21):e350‐e408. doi:10.1161/CIRCUALTIONAHA.108.189742
Peric S, Bjelica B, Aleksic K, et al. Heart involvement in patients with myotonic dystrophy type 2. Acta Neurol Belg. 2019;119(1):77‐82. doi:10.1007/s13760-018-1052-3
Sansone VA, Brigonzi E, Schoser B, et al. The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): long‐term outcomes. Int J Cardiol. 2013;168(2):1147‐1153. doi:10.1016/j.ijcard.2012.11.076
Shaunak S, Orrell R, Henderson L, Kennard C. Saccades and smooth pursuit in myotonic dystrophy. J Neurol. 1999;246(7):600‐606. doi:10.1007/s004150050411
Taylor RG, Abresch RT, Lieberman JS, Fowler WM, Entrikin RK. In vivo quantification of muscle contractility in humans: healthy subjects and patients with myotonic muscular dystrophy. Arch Phys Med Rehabil. 1992;73(3):233‐236.
Shields RK, Lee J, Buelow A, et al. Myotonic dystrophy type 1 alters muscle twitch properties, spinal reflexes, and perturbation‐induced trans‐cortical reflexes. Muscle Nerve. 2020;61(2):205‐212. doi:10.1002/mus.26767
Caso F, Agosta F, Peric S, et al. Cognitive impairment in myotonic dystrophy type 1 is associated with white matter damage. PLoS One. 2014;9(8):e104697. doi:10.1371/journal.pone.0104697
Minnerop M, Weber B, Schoene‐Bake JC, et al. The brain in myotonic dystrophy 1 and 2: evidence for a predominant white matter disease. Brain. 2011;134(12):3530‐3546. doi:10.1093/brain/awr299
Osanai R, Kinoshita M, Hirose K. Saccadic slowing in myotonic dystrophy and CTG repeat expansion. J Neurol. 1998;245(10):674‐680. doi:10.1007/s004150050266
Choi J‐Y, Kim H‐J, Kim J‐S. Recent advances in head impulse test findings in central vestibular disorders. Neurology. 2018;90(13):602‐612. doi:10.1212/WNL.0000000000005206
Berends J, Tieleman AA, Horlings CGC, et al. High incidence of falls in patients with myotonic dystrophy type 1 and 2: a prospective study. Neuromuscul Disord. 2019;29(10):758‐765. doi:10.1016/j.nmd.2019.08.012

Auteurs

Zeljka Calic (Z)

Department of Neurophysiology, Liverpool Hospital, Sydney, New South Wales, Australia.
South Western Sydney Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Stojan Peric (S)

Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Milorad Vujnic (M)

Department of Pathophysiology, Faculty of Medicine, University of Banja Luka, Institute of Physical Medicine and Rehabilitation "Dr Miroslav Zotovic", Banja Luka, Bosnia and Herzegovina.

Bogdan Bjelica (B)

Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Department of Neurology, Hannover Medical School, Hannover, Germany.

Ivo Bozovic (I)

Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Vidosava Rakocevic-Stojanovic (V)

Neurology Clinic, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.

Andrew Bradshaw (A)

Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.

James G Colebatch (JG)

Institute of Neurological Sciences, Prince of Wales Clinical School, University of New South Wales, Sydney, New South Wales, Australia.

Miriam S Welgampola (MS)

Institute of Clinical Neurosciences, Royal Prince Alfred Hospital, Central Clinical School, University of Sydney, Sydney, New South Wales, Australia.

Classifications MeSH